|
TMLHE expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.88578058618805E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.91660046009201E-10 |
| Normal-vs-Stage2 |
3.57869999967342E-07 |
| Normal-vs-Stage3 |
5.55111512312578E-16 |
| Normal-vs-Stage4 |
1.62492241884138E-12 |
| Stage1-vs-Stage2 |
2.873400E-01 |
| Stage1-vs-Stage3 |
8.26919999999953E-05 |
| Stage1-vs-Stage4 |
1.51129000000028E-05 |
| Stage2-vs-Stage3 |
1.118980E-01 |
| Stage2-vs-Stage4 |
3.114300E-02 |
| Stage3-vs-Stage4 |
4.502400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.45439216225896E-14 |
| Normal-vs-AfricanAmerican |
8.38706881722828E-12 |
| Normal-vs-Asian |
2.203100E-03 |
| Caucasian-vs-AfricanAmerican |
1.677800E-01 |
| Caucasian-vs-Asian |
9.513000E-01 |
| AfricanAmerican-vs-Asian |
6.121400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.66133814775094E-16 |
| Normal-vs-Female |
7.8296036321035E-11 |
| Male-vs-Female |
2.919700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.50219999667445E-08 |
| Normal-vs-Age(41-60Yrs) |
4.0867309536452E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63125069008174E-12 |
| Normal-vs-Age(81-100Yrs) |
1.02980000005193E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.485400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.591000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.771000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.543190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.623600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.618600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.188300E-02 |
| Normal-vs-Grade 2 |
8.52670045681236E-10 |
| Normal-vs-Grade 3 |
1.63313806922361E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
4.611600E-01 |
| Grade 1-vs-Grade 3 |
6.891600E-02 |
| Grade 1-vs-Grade 4 |
1.188220E-04 |
| Grade 2-vs-Grade 3 |
3.759400E-03 |
| Grade 2-vs-Grade 4 |
2.00299998809328E-09 |
| Grade 3-vs-Grade 4 |
6.40299999999927E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.41600000000708E-06 |
| Normal-vs-ccB subtype |
1.62492241884138E-12 |
| ccA subtype-vs-ccB subtype |
3.0343000001487E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.75881531561117E-12 |
| Normal-vs-N1 |
1.77810000057121E-09 |
| N0-vs-N1 |
1.798490E-02 |
|
|
